These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 35505833)
41. The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C). Panaro S; Cattalini M Front Med (Lausanne); 2021; 8():747190. PubMed ID: 34778310 [TBL] [Abstract][Full Text] [Related]
42. COVID-19 Vaccine Reactogenicity and Vaccine Attitudes Among Children and Parents/Guardians After Multisystem Inflammatory Syndrome in Children or COVID-19 Hospitalization: September 2021-May 2022. Yousaf AR; Kunkel A; Abrams JY; Shah AB; Hammett TA; Arnold KE; Beltran YL; Laham FR; Kao CM; Hunstad DA; Hussaini L; Baida N; Salazar L; Perez MA; Rostad CA; Godfred-Cato S; Campbell AP; Belay ED Pediatr Infect Dis J; 2023 Mar; 42(3):252-259. PubMed ID: 36729032 [TBL] [Abstract][Full Text] [Related]
43. Multisystem Inflammatory Syndrome in a 12-Year-old Boy After mRNA-SARS-CoV-2 Vaccination. Abdelgalil AA; Saeedi FA Pediatr Infect Dis J; 2022 Mar; 41(3):e93-e94. PubMed ID: 34955518 [TBL] [Abstract][Full Text] [Related]
45. Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2-11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population study. Toledo-Romaní ME; Valenzuela-Silva C; Montero-Díaz M; Iñiguez-Rojas L; Rodríguez-González M; Martínez-Cabrera M; Puga-Gómez R; German-Almeida A; Fernández-Castillo S; Climent-Ruiz Y; Santana-Mederos D; López-González L; Morales-Suárez I; Doroud D; Valdés-Balbín Y; García-Rivera D; Van der Stuyft P; Vérez-Bencomo V Lancet Reg Health Am; 2024 Jun; 34():100750. PubMed ID: 38699214 [TBL] [Abstract][Full Text] [Related]
46. Multisystem inflammatory syndrome in children during the first two years of the COVID-19 pandemic in Luxembourg. Ooms C; Mossong J; Vergison A; Biver A; Wagner K; Niel O; Parrish A; Abdelrahman TT; de la Fuente Garcia I Front Pediatr; 2023; 11():1141074. PubMed ID: 37090918 [TBL] [Abstract][Full Text] [Related]
47. Detection of faecal SARS-CoV-2 RNA in a prospective cohort of children with multisystem inflammatory syndrome (MIS-C). Parodi E; Carpino A; Franchitti E; Pruccoli G; Denina M; Pagliero F; Ramenghi U; Traversi D Epidemiol Prev; 2021; 45(6):522-527. PubMed ID: 34841834 [TBL] [Abstract][Full Text] [Related]
48. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Nakra NA; Blumberg DA; Herrera-Guerra A; Lakshminrusimha S Children (Basel); 2020 Jul; 7(7):. PubMed ID: 32630212 [TBL] [Abstract][Full Text] [Related]
49. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Sperotto F; Friedman KG; Son MBF; VanderPluym CJ; Newburger JW; Dionne A Eur J Pediatr; 2021 Feb; 180(2):307-322. PubMed ID: 32803422 [TBL] [Abstract][Full Text] [Related]
50. Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex. Patone M; Mei XW; Handunnetthi L; Dixon S; Zaccardi F; Shankar-Hari M; Watkinson P; Khunti K; Harnden A; Coupland CAC; Channon KM; Mills NL; Sheikh A; Hippisley-Cox J Circulation; 2022 Sep; 146(10):743-754. PubMed ID: 35993236 [TBL] [Abstract][Full Text] [Related]
51. A Case of Adult Multisystem Inflammatory Syndrome Following COVID-19 Vaccine. Brown M; Garbajs NZ; Zec S; Mushtaq H; Khedr A; Jama AB; Rauf I; Mir M; Korsapati AR; Jain S; Koritala T; Adhikari R; Lal A; Gajic O; Domecq JP; Goksoy S; Bartlett B; Sharma A; Jain NK; Khan SA J Community Hosp Intern Med Perspect; 2022; 12(4):7-13. PubMed ID: 36262897 [TBL] [Abstract][Full Text] [Related]
52. Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination. Wangu Z; Swartz H; Doherty M BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354564 [TBL] [Abstract][Full Text] [Related]
53. Multisystem Inflammatory Syndrome in Children Among Persons Who Completed a Two-dose COVID-19 Vaccine Primary Series Compared With Those Reporting No COVID-19 Vaccination, US National MIS-C Surveillance. Yousaf AR; Miller AD; Lindsey K; Shah AB; Wu MJ; Melgar M; Zambrano LD; Campbell AP Pediatr Infect Dis J; 2023 Dec; 42(12):e476-e478. PubMed ID: 37725819 [TBL] [Abstract][Full Text] [Related]
54. A 7-Year-Old Boy and a 14-Year-Old Girl Initially Diagnosed with Toxic Shock Syndrome and Tested Positive for SARS-CoV-2 Infection, Supporting a Diagnosis of Multisystem Inflammatory Syndrome in Children (MIS-C). Giordano S; Failla MC; Li Cavoli MG; Romano D; Vanella V; Caruso C; Chillura I; Maggio MC Am J Case Rep; 2021 Oct; 22():e931570. PubMed ID: 34635631 [TBL] [Abstract][Full Text] [Related]
55. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022. Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977 [TBL] [Abstract][Full Text] [Related]
56. Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic. Alkan F; Bircan O; Bal A; Bayturan S; Zengin N; Coskun S BMC Pediatr; 2024 Jul; 24(1):485. PubMed ID: 39080588 [TBL] [Abstract][Full Text] [Related]
57. Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance. Maltezou HC; Hatziantoniou S; Theodoridou K; Vasileiou K; Anastassopoulou C; Tsakris A Vaccine; 2023 Mar; 41(14):2382-2386. PubMed ID: 36872145 [TBL] [Abstract][Full Text] [Related]
58. Educational Setting and SARS-CoV-2 Transmission Among Children With Multisystem Inflammatory Syndrome: A French National Surveillance System. Guenver C; Oualha M; Levy C; Antona D; Madhi F; Toubiana J; Lachaume N; Javouhey E; Lorrot M; Yang DD; Levy M; Caseris M; Galeotti C; Ovaert C; Wiedemann A; Girardin ML; Rybak A; Cohen R; Belot A; Angoulvant F; Ouldali N Front Pediatr; 2021; 9():745364. PubMed ID: 34765576 [No Abstract] [Full Text] [Related]
59. Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome. Lo Vecchio A; Garazzino S; Smarrazzo A; Venturini E; Poeta M; Berlese P; Denina M; Meini A; Bosis S; Galli L; Cazzato S; Nicolini G; Vergine G; Giacchero R; Ballardini G; Dodi I; Salvini FM; Manzoni P; Ferrante G; Quadri V; Campana A; Badolato R; Villani A; Guarino A; Gattinara GC; JAMA Netw Open; 2021 Dec; 4(12):e2139974. PubMed ID: 34928354 [TBL] [Abstract][Full Text] [Related]
60. Cardiovascular impact of COVID-19 with a focus on children: A systematic review. Rodriguez-Gonzalez M; Castellano-Martinez A; Cascales-Poyatos HM; Perez-Reviriego AA World J Clin Cases; 2020 Nov; 8(21):5250-5283. PubMed ID: 33269260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]